Pharmaceutical and Energy-Based Management of Sexual Problems in Women.
Cognitive sexual arousal
Electric stimulation therapy
Female sexual dysfunction
Genital sexual arousal
Hypoactive sexual desire
Laser therapy
Medicalization
Radiofrequency therapy
Journal
The Urologic clinics of North America
ISSN: 1558-318X
Titre abrégé: Urol Clin North Am
Pays: United States
ID NLM: 0423221
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
entrez:
4
10
2021
pubmed:
5
10
2021
medline:
28
10
2021
Statut:
ppublish
Résumé
This article summarizes and critiques the evidence for use of available pharmacotherapies (vasoactive, psychoactive, and hormonal medications) and energy-based therapies (laser, radiofrequency, shockwave, and neurostimulation) for treatment of female sexual dysfunction. The enthusiasm with which energy-based treatments for sexual dysfunction have been adopted is disproportionate to the amount of data currently available to support their clinical use. Pharmacotherapy for female sexual dysfunction has considerably more research evidence to justify its use. Patients must be empowered to make an informed, autonomous determination as to whether the risk/reward ratio favors the use of pharmacotherapy, energy-based therapy, or some other treatment intervention.
Identifiants
pubmed: 34602169
pii: S0094-0143(21)01856-5
doi: 10.1016/j.ucl.2021.06.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
473-486Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.